2013
DOI: 10.1016/j.rasd.2012.08.007
|View full text |Cite
|
Sign up to set email alerts
|

Association between plasma levels of transforming growth factor-β1, IL-23 and IL-17 and the severity of autism in Egyptian children

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
21
0
2

Year Published

2017
2017
2021
2021

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 31 publications
(24 citation statements)
references
References 33 publications
1
21
0
2
Order By: Relevance
“…Our TGF-β 1 levels found before AIT intervention are similar to those reported earlier [21,23] in typically developing children with autism, which significantly increased up to 105% 3 months after AIT with improvement in social behavioral functions. Taken together, these findings suggest that TGF-β 1 may play a role in the pathophysiology of ASD, although further work is needed to confirm these reports.…”
Section: Discussionsupporting
confidence: 88%
See 2 more Smart Citations
“…Our TGF-β 1 levels found before AIT intervention are similar to those reported earlier [21,23] in typically developing children with autism, which significantly increased up to 105% 3 months after AIT with improvement in social behavioral functions. Taken together, these findings suggest that TGF-β 1 may play a role in the pathophysiology of ASD, although further work is needed to confirm these reports.…”
Section: Discussionsupporting
confidence: 88%
“…Given the key role of TGF-β 1 in brain development and inflammation, serum levels of TGF-β 1 were reported to be significantly lower in autistics than in age-and gender-matched controls [21,23]. The reduced TGF-β 1 levels may lead to inappropriate regulation of immune responses as well as the development of neuroinflammation in ASD.…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…In what appears to be an important extension of previous studies, our findings are the first to show significantly reduced concentrations of CXCL9 in children with ASD compared to TD controls. The reduced levels of CXCL9 may be related to the slight decrease in the levels of the Th1-related chemokine CXCL10 in the ASD and ASD + ADHD groups, given that CXCL9 is a chemokine that is structurally and functionally related to CXCL10, which binds to a common inflammatory chemokine receptor, CXCR3, to coordinate inflammation in a variety of human diseases (9, 33). In fact, a positive correlation was found between levels of CXCL9 and CXCL10 in the present study, r  = 0.35, p  = 0.04, indicating that both of these chemokines may have important implications in the inflammatory mechanism in ASD, in that their levels of production show similar patterns.…”
Section: Discussionmentioning
confidence: 99%
“…Hashim et al found significantly lower levels of TGF‐β and IL‐23 among children with ASD in comparison with the control group . Furthermore, they did not find a significant difference in IL‐17 levels in children with ASD than the control group …”
Section: Role Of Inflammation In the Pathophysiology Of Npdmentioning
confidence: 96%